Agenda
The HTI summit programme of events
11:45 – 12:40
Registration and lunch
12:40-12:45
Welcome – Dr Ralph Holme (RNID, UK)
12:45-13:00
with Hugh Strickland (Aaron & Partners Solicitors, UK)
Session 1
Bringing new treatments to the clinic – lessons learned along the way, chaired by Prof Anne Schilder (NIHR UCLH BRC, UK):
13:00-13:15
‘Drug discovery and development challenges in hearing disorders’
with Dr Alan C Foster (Jobral Consulting, USA)
13:15-13:30
‘ACOU085 – lessons learned from developing a locally administered otoprotectant’
with Dr Jonas Dhyrfjeld-Johnsen (Acousia Therapeutics, Germany)
13:30-13:45
with Mr Jeremy DiCandilo (Fennec Pharmaceuticals, USA)
13:45-14:15
Speakers panel discussion and audience Q&A
14:15-15:00
Coffee and networking
15:00-15:15
‘The Hearing Therapeutics Initiative‘
with Dr Catherine Perrodin (RNID, UK)
Session 2
Basic science to the rescue – open challenges in hearing therapeutics development, chaired by Prof Jonathan Gale (UCL Ear Institute):
15:15-15:30
‘Hearing in background noise: the path toward future treatments using digital evaluation’
with Dr Gaëlle Naert (CILcare, France)
15:30-15:45
‘Segmenting the biological causes of hearing loss’
with Prof Karen P Steel (King’s College London, UK)
15:45-16:00
´ORC-13661: from fish tank to first-in-class drug’
with Prof David W Raible (Oricula Therapeutics, USA)
16:00-16:15
Speakers panel discussion and audience Q&A
16:15-17:00
Fireside chat: Bridging the gap between academia and industry
Dr Simon Chandler and Prof Marcelo Rivolta (Rinri Therapeutics, UK) in conversation with Dr Barbara Domayne-Hayman (Autifony/Francis Crick Institute, UK)
17:00-17:05
Closing remarks with Prof Jonathan Gale
17:00-19:00
Networking session & drinks reception
Satellite event of the 58th Inner Ear Biology Meeting